Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23267)

• Formulation Name: Relugolix 120 mg tablet
• Company: Myovant Sciences

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Relugolix	(DMK7IWL)	Prostate cancer	2C82.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Haematite red	(E00236)	14833	Colorant
Hydroxypropyl cellulose	(E00632)	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent